These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 18368577)

  • 1. Reliability of the vestibular evoked myogenic potential test in assessing intratympanic gentamicin therapy in Meniere's disease.
    Ozluoglu LN; Akkuzu G; Ozgirgin N; Tarhan E
    Acta Otolaryngol; 2008 Apr; 128(4):422-6. PubMed ID: 18368577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
    Helling K; Schönfeld U; Clarke AH
    Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-shot, low-dose intratympanic gentamicin in Ménière disease: role of vestibular-evoked myogenic potentials and caloric test in the prediction of outcome.
    Gode S; Celebisoy N; Akyuz A; Gulec F; Karapolat H; Bilgen C; Kirazli T
    Am J Otolaryngol; 2011; 32(5):412-6. PubMed ID: 20851502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
    Kaplan DM; Hehar SS; Bance ML; Rutka JA
    Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does intratympanic gentamicin treatment for Meniere's disease cause complete vestibular ablation?
    Hone SW; Nedzelski J; Chen J
    J Otolaryngol; 2000 Apr; 29(2):83-7. PubMed ID: 10819105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEMPs and dynamic posturography after intratympanic gentamycin in Menière's disease.
    Picciotti PM; Fiorita A; Di Nardo W; Quaranta N; Paludetti G; Maurizi M
    J Vestib Res; 2005; 15(3):161-8. PubMed ID: 16179764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratympanic gentamicin therapy for intractable Ménière's disease.
    De Beer L; Stokroos R; Kingma H
    Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the stage of Meniere's disease using vestibular evoked myogenic potentials.
    Young YH; Huang TW; Cheng PW
    Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):815-8. PubMed ID: 12925337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent of lesions in idiopathic sudden hearing loss with vertigo: study using click and galvanic vestibular evoked myogenic potentials.
    Iwasaki S; Takai Y; Ozeki H; Ito K; Karino S; Murofushi T
    Arch Otolaryngol Head Neck Surg; 2005 Oct; 131(10):857-62. PubMed ID: 16230586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratympanic gentamicin for the treatment of unilateral Meniere's disease.
    Kaplan DM; Nedzelski JM; Chen JM; Shipp DB
    Laryngoscope; 2000 Aug; 110(8):1298-305. PubMed ID: 10942130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N; Boleas MS; Martin E
    Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratympanic gentamicin injections for the treatment of Ménière's disease.
    Katzenell U; Gordon M; Page M
    Otolaryngol Head Neck Surg; 2010 Nov; 143(5 Suppl 3):S24-9. PubMed ID: 20970688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vestibular evoked myogenic potential (VEMP) in patients with Ménière's disease with drop attacks.
    Timmer FC; Zhou G; Guinan JJ; Kujawa SG; Herrmann BS; Rauch SD
    Laryngoscope; 2006 May; 116(5):776-9. PubMed ID: 16652086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of tone burst vestibular evoked myogenic potentials at threshold in acute and stable Ménière's disease.
    Osei-Lah V; Ceranic B; Luxon LM
    J Laryngol Otol; 2008 May; 122(5):452-7. PubMed ID: 17605832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
    Hsieh LC; Lin HC; Tsai HT; Ko YC; Shu MT; Lin LH
    Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.